Listos, J.; Listos, P.; Baranowska-Bosiacka, I.; Karpiuk, A.; Filarowska, J.; Łupina, M.; Słowik, T.; Zawiślak, S.; Kotlińska, J.
Linagliptin, a Selective Dipeptidyl Peptidase-4 Inhibitor, Reduces Physical and Behavioral Effects of Morphine Withdrawal. Molecules 2022, 27, 2478.
https://doi.org/10.3390/molecules27082478
AMA Style
Listos J, Listos P, Baranowska-Bosiacka I, Karpiuk A, Filarowska J, Łupina M, Słowik T, Zawiślak S, Kotlińska J.
Linagliptin, a Selective Dipeptidyl Peptidase-4 Inhibitor, Reduces Physical and Behavioral Effects of Morphine Withdrawal. Molecules. 2022; 27(8):2478.
https://doi.org/10.3390/molecules27082478
Chicago/Turabian Style
Listos, Joanna, Piotr Listos, Irena Baranowska-Bosiacka, Agata Karpiuk, Joanna Filarowska, Małgorzata Łupina, Tymoteusz Słowik, Sylwia Zawiślak, and Jolanta Kotlińska.
2022. "Linagliptin, a Selective Dipeptidyl Peptidase-4 Inhibitor, Reduces Physical and Behavioral Effects of Morphine Withdrawal" Molecules 27, no. 8: 2478.
https://doi.org/10.3390/molecules27082478
APA Style
Listos, J., Listos, P., Baranowska-Bosiacka, I., Karpiuk, A., Filarowska, J., Łupina, M., Słowik, T., Zawiślak, S., & Kotlińska, J.
(2022). Linagliptin, a Selective Dipeptidyl Peptidase-4 Inhibitor, Reduces Physical and Behavioral Effects of Morphine Withdrawal. Molecules, 27(8), 2478.
https://doi.org/10.3390/molecules27082478